Literature DB >> 32433530

PDAC resistance to immunotherapy - a role for autophagy?

Jordan Hindson1.   

Abstract

Mesh：

Year:  2020        PMID： 32433530     DOI： 10.1038/s41575-020-0318-4

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  3 in total

1.  Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer.

Authors:  Carmine Carbone; Geny Piro; Antonio Agostini; Pietro Delfino; Francesco De Sanctis; Vincenzo Nasca; Francesco Spallotta; Claudio Sette; Maurizio Martini; Stefano Ugel; Vincenzo Corbo; Paola Cappello; Emilio Bria; Aldo Scarpa; Giampaolo Tortora
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 12.469

Review 2.  Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma.

Authors:  Samer S AlMasri; Mazen S Zenati; Annissa Desilva; Ibrahim Nassour; Brian A Boone; Aatur D Singhi; David L Bartlett; Lance A Liotta; Virginia Espina; Patricia Loughran; Michael T Lotze; Alessandro Paniccia; Herbert J Zeh; Amer H Zureikat; Nathan Bahary
Journal:  Cancer Med       Date:  2021-09-24       Impact factor: 4.452

Review 3.  Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies.

Authors:  Anthony Turpin; Cindy Neuzillet; Elise Colle; Nelson Dusetti; Rémy Nicolle; Jérôme Cros; Louis de Mestier; Jean-Baptiste Bachet; Pascal Hammel
Journal:  Ther Adv Med Oncol       Date:  2022-09-06       Impact factor: 5.485
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.